Interleukin-17 Gene Polymorphisms Contribute to Cancer Risk
Epidemiological studies have suggested that interleukin-17 (IL-17) polymorphisms are associated with cancer risk. However, the results of these studies are inconsistent. Therefore, we performed a meta-analysis to obtain a precise conclusion. Odds ratios (ORs) with 95% confidence intervals (CIs) were...
Saved in:
Main Authors: | Yu-Ming Niu, Hua Yuan, Yu Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2014/128490 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Association between Polymorphisms in Interleukin-17A and -17F Genes and Chronic Periodontal Disease
by: Jôice Dias Corrêa, et al.
Published: (2012-01-01) -
Interleukin-16 Polymorphism Is Associated with an Increased Risk of Ischemic Stroke
by: Xiao-li Liu, et al.
Published: (2013-01-01) -
The Influence of Interleukin 17A and IL17F Polymorphisms on Chronic Periodontitis Disease in Brazilian Patients
by: Joana Maira Valentini Zacarias, et al.
Published: (2015-01-01) -
The role of interleukin-17 in inflammation-related cancers
by: Xingru Zhang, et al.
Published: (2025-01-01) -
Association of the Interleukin-10-592C/A Polymorphism and Cervical Cancer Risk: A Meta-Analysis
by: Brehima Diakite, et al.
Published: (2022-01-01)